Axios @axios
Federal health regulators will soon face their next controversial vaccine decision: whether to authorize Pfizer's vaccine for children younger than 5, despite ongoing questions around dosing and effectiveness. https://t.co/ELkqiLX9fy — PolitiTweet.org